Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Exercise type and timing for blood pressure and eye pressure in glaucoma

Official title: The ACHIEVE-project: Advancing Cardiovascular and Ocular Health In Eye Patients. The Acute Effect of Exercise Type And Timing on Ambulatory Blood Pressure and Intra-Ocular Pressure in Individuals With Glaucoma.

Run by KU Leuven · NCT07413614 · Data updated 2026-11-12

This study tests whether different kinds and times of exercise can safely lower blood pressure and eye pressure in adults with primary open-angle glaucoma and high blood pressure.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorKU Leuven
Academic / other
Locations1 site (Leuven)
StatusRecruiting
StartedJuly 31, 2026
Main results expectedMarch 2027
Study endsMarch 2027
Registry record updatedOctober 29, 2026
Trial IDNCT07413614 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with primary open-angle glaucoma and elevated blood pressure, not recently changing glaucoma or antihypertensive therapy and able to perform exercise.

Probably not a fit

Individuals unable to exercise safely or with uncontrolled office or home BP despite treatment may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The ACHIEVE-project investigates the short-term safety and effects of aerobic, isometric, and moderate-to-high intensity exercise performed at different times of day on 24-hour ambulatory blood pressure and intraocular pressure in people with POAG and elevated BP. Participants will undergo supervised exercise sessions to measure post-exercise blood pressure changes and variability, aiming to identify the most beneficial and safe protocols. The study design focuses on feasibility, safety, and physiological responses rather than long-term outcomes. Results could inform non-drug strategies to manage blood pressure and eye pressure in this patient population.

Why it matters

Potential benefit: If successful, patients could gain non-pharmacologic options to help control blood pressure and intraocular pressure.

How similar studies have gone: Previous research supports short-term blood pressure reductions after exercise, but this exact combination of POAG, BP criteria, and timing modalities is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
* At least 18 years of age at the time of signing the Informed Consent Form (ICF)
* Patients with POAG AND \[elevated BP OR hypertension (Average SBP on Home BP ≥120 mmHg AND/OR Average DBP on Home BP ≥70 mmHg) with or without the use of anti-hypertensive medication\]
* Patients without recent changes in medication and glaucoma care within the past four weeks.

Exclusion Criteria:

* Not able to provide informed consent
* SBP and/or DBP are ≥ 150 mmHg and/or ≥ 95 mmHg, respectively, on office BP at screening AND on home BP measurement conducted in the week following screening (to identify White Coat Hypertension) to ensure safety. These patients require referral for early treatment.
* Aberrant cardiopulmonary exercise test (CPET) at screening (Life-threatening arrhythmias, ischemia,…)
* Unable to perform one or more of the four exercise sessions due to physical and or mental limitations (severe lung disease, musculoskeletal issues, unstable angina,…)
* Severe osteoarthritis pending knee replacement surgery (these patients may be unable to perform the IRE (i.e. wall squat exercise)
* Unable to communicate in Dutch
* Active malignancy
* Participation in an interventional Trial with an investigational medicinal product (IMP), exercise intervention or device
* Unwillingness to repeat ABPM
* Relative contraindications to ABPM: diagnosed atrial fibrillation, nighttime workers, occupational drivers

Where it's running

  • UZ Leuven/KU Leuven
    Leuven, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.